219 related articles for article (PubMed ID: 7617800)
1. Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
Hyde TM; Egan MF; Wing LL; Wyatt RJ; Weinberger DR; Kleinman JE
Psychopharmacology (Berl); 1995 Mar; 118(2):142-9. PubMed ID: 7617800
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoate.
Egan MF; Ferguson JN; Hyde TM
Brain Res Bull; 1995; 38(4):355-63. PubMed ID: 8535858
[TBL] [Abstract][Full Text] [Related]
3. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
[TBL] [Abstract][Full Text] [Related]
5. Haloperidol versus risperidone on rat "early onset" vacuous chewing.
Marchese G; Bartholini F; Casu MA; Ruiu S; Casti P; Congeddu E; Tambaro S; Pani L
Behav Brain Res; 2004 Feb; 149(1):9-16. PubMed ID: 14739005
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose.
Egan MF; Hyde TM; Kleinman JE; Wyatt RJ
Psychopharmacology (Berl); 1995 Jan; 117(1):74-81. PubMed ID: 7724705
[TBL] [Abstract][Full Text] [Related]
7. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia.
Hashimoto T; Ross DE; Gao XM; Medoff DR; Tamminga CA
Psychopharmacology (Berl); 1998 May; 137(2):107-12. PubMed ID: 9629996
[TBL] [Abstract][Full Text] [Related]
8. Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.
Hamid EH; Hyde TM; Baca SM; Egan MF
Brain Res; 1998 Jun; 796(1-2):291-5. PubMed ID: 9689480
[TBL] [Abstract][Full Text] [Related]
9. The relationship between motor effects in rats following acute and chronic haloperidol treatment.
Jørgensen HA; Andreassen OA; Hole K
Psychopharmacology (Berl); 1994 Sep; 116(1):89-92. PubMed ID: 7862936
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains.
Tamminga CA; Dale JM; Goodman L; Kaneda H; Kaneda N
Psychopharmacology (Berl); 1990; 102(4):474-8. PubMed ID: 1982902
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats.
Dhingra D; Goswami S; Gahalain N
Nutr Neurosci; 2018 Nov; 21(9):667-675. PubMed ID: 28641484
[TBL] [Abstract][Full Text] [Related]
12. Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.
Bordia T; McIntosh JM; Quik M
J Pharmacol Exp Ther; 2012 Mar; 340(3):612-9. PubMed ID: 22144565
[TBL] [Abstract][Full Text] [Related]
13. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Naidu PS; Kulkarni SK
Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
[TBL] [Abstract][Full Text] [Related]
14. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol.
Meshul CK; Andreassen OA; Allen C; Jørgensen HA
Psychopharmacology (Berl); 1996 Jun; 125(3):238-47. PubMed ID: 8815959
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum.
Roberts RC; Gaither LA; Gao XM; Kashyap SM; Tamminga CA
Synapse; 1995 Jul; 20(3):234-43. PubMed ID: 7570355
[TBL] [Abstract][Full Text] [Related]
16. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat.
McCullumsmith RE; Stincic TL; Agrawal SM; Meador-Woodruff JH
Eur J Pharmacol; 2003 Sep; 477(2):101-12. PubMed ID: 14519413
[TBL] [Abstract][Full Text] [Related]
18. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
19. Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias.
Kelley JJ; Roberts RC
J Neural Transm (Vienna); 2004 Aug; 111(8):1075-91. PubMed ID: 15254795
[TBL] [Abstract][Full Text] [Related]
20. Effects of rating parameters on assessment of neuroleptic-induced vacuous chewing movements.
Egan MF; Ferguson J; Hyde TM
Pharmacol Biochem Behav; 1996 Feb; 53(2):401-10. PubMed ID: 8808150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
